| Value | ₹0.01 Cr |
|---|
NSE filing, NSE: KRMAYURVED. Summary written from the filing by ALFA Finder's alert engine.
KRM Ayurveda Ltd: key numbers
- Share price
- ₹231.10
- Market cap
- ₹491.3 Cr
- Revenue (annual)
- ₹101.7 Cr
- Net profit (annual)
- ₹20.12 Cr
- P/E (TTM)
- 24.4×Sector 34.1×
- Promoter holding
- 69.30%+0.00% QoQ
- FII holding
- 1.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from KRM Ayurveda Ltd
All →KRM Ayurveda Board Meeting Date
KRM Ayurveda will hold a board meeting on 13-Nov-2026 to consider unaudited half-yearly results for September 2026. The trading window closes from 01-Oct-2026 until 15-Nov-2026.
KRM Ayurveda Other Announcement
KRM Ayurveda Limited filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. This pertains to the period ending September 30, 2026.
KRM Ayurveda Capacity Expansion
KRM Ayurveda established a new day care center at Ghaziabad, Uttar Pradesh. The 3000 sq ft unit began operations on 23 September 2026 under a 9-year lease, expanding its footprint.
- Execution
- 9 years (lease period)
KRM Ayurveda Business Update
KRM Ayurveda Ltd received NABH accreditation for its Panchakarma day care center in Dwarka, New Delhi. This reflects the company's commitment to high healthcare service standards.
KRM Ayurveda Annual General Meeting
KRM Ayurveda held its 07th AGM on September 30, 2026, where shareholders approved financial statements, director appointments, related party transactions, and IPO proceeds utilization.
KRM Ayurveda Business Update
KRM Ayurveda Limited received NABH accreditation for its Panchakarma day care center in Noida, Uttar Pradesh. This certification reflects the company's commitment to high healthcare standards.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr